Turning scientific discoveries into better treatments

At UQ Diamantina Institute, our research leaders translate scientific discoveries into effective medical treatments with the potential to change lives on a global scale. Our world-class research facilities located on the Princess Alexandra Hospital campus enable researchers to maintain close clinical ties with colleagues and patients that allow them to develop, refine and test promising new therapies.

1 million lives and counting

UQDI researchers have an impressive track record of success. More than 170 million doses of the cervical cancer vaccine Gardasil have been administered to young people in countries all over the world. The development of the vaccine by Professor Ian Frazer AC and his late colleague Dr Jian Zhou means a disease that kills 270,000 women per year will soon be a thing of the past.

More recently, in June 2015 we announced a breakthrough achievement toward development of a vaccine to prevent and treat rheumatoid arthritis, a debilitating autoimmune disease currently affecting more than 450,000 Australians. Our researchers are actively pursuing preventive or curative treatments for a variety of common diseases aligned around three core areas.


Our cancer researchers seek to understand the biological mechanisms involved in cancer development, progression and response to treatment. They are using novel techniques to investigate how viruses can trigger cancers and how genetic changes can result in cancer. Their ultimate goal is to turn our immune system into a cancer fighting weapon that can aid treatment of such deadly cancers as melanoma, breast and prostate cancer, and blood cancers like leukaemia, lymphoma and myeloma.


Our immunology researchers seek to develop therapies for common but debilitating autoimmune diseases such as rheumatoid arthritis and type 1 diabetes. Immersed within the immunology group is a highly specialized group of researchers looking at how our diet and environment influence, our microbiome, the microbial communities in our gut and on our skin.

Genomic Medicine

Our genomic medicine research focuses on understanding the genetic causes of many common human diseases. We use cutting-edge DNA sequencing, genotyping and proteomic technologies to research a wide range of complex diseases, including cancer, arthritis, motor neuron disease, osteoporosis, diabetes, eczema and other chronic illnesses. With a better understanding of genetic causes, and a greater ability to identify high risk patients, we can work to develop highly targeted therapies that have a greater chance of success.

We invite you to make a gift in support of vital research happening within our laboratories every day. Your generosity will help us change lives on a global scale now and in the future.

You can choose from a range of donor options, including Fellowships for early-to mid-career scientists, student scholarships, equipment, funding specific areas of research or naming a Professorial Chair.

  • Donate online to The University of Queensland Diamantina Institute Research.
  • Leave a bequest for The University of Queensland Diamantina Institute Research. Please call Nina Mullins, Bequests Manager, on 07 3346 3904 or email bequest@uq.edu.au.
  • Speak with UQDI's Advancement Manager, about getting involved and offering your support. You can call Nicole Zanyat on (07) 3443 7026, or mobile: 0448 413 157, or email n.zanyat@uq.edu.au

Under current legislation, gifts greater than $2 to The University of Queensland and UQDI are tax deductible.